Misato Nagai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Misato Nagai has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anonh Xeuatvongsa
National Immunization Program, Ministry of Health, Lao PDR, Simeuang Road, Vientiane, Lao PDR
1 shared publication - Chansay Pathammavong
Ministry of Health
1 shared publication - Hironori Okabayashi
Country Office for Lao People’s Democratic Republic
1 shared publication - Katsuhiro Komase
Department of Virology 3, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan
1 shared publication - Keiko Murano
Department of Virology 3, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan
1 shared publication - Kenichi Komada
Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 19 March 2019
- Published by Springer Nature in BMC Research Notes
- Vol. 12 (1) , 155
Seroprevalence of mumps before the introduction of mumps-containing vaccine in Lao PDR: results from a nationwide cross-sectional population-based survey
Objective: Mumps-containing vaccine is currently not a component of the national immunization schedule in Lao People's Democratic Republic (PDR). Mumps itself is not a notifiable disease in the country and the seroprevalence of anti-mumps immunoglobulin G (IgG) in the general population is unknown. In this study, anti-mumps IgG was measured in 2058 blood samples to evaluate population immunity in the country. Results: The seroprevalence of anti-mumps IgG showed a gradual increase with increasing age, starting at 10.6% (95% CI 7.4-13.7) in participants aged 1-2 years, and almost plateaued at about 75% in individuals older than 11-12 years, though it still tended toward a small increase up to 89.6% (95% CI 86.6-92.6) in participants aged 40 years or older. Compared with the results of previous studies, this increase with increasing age is less marked and the plateau of anti-mumps seroprevalence is lower. We attribute this result mainly to the lower population density in Lao PDR.
- 19 March 2019
- Published by Springer Nature in BMC Research Notes
- Vol. 12 (1) , 155
Open AccessSeroprevalence of mumps before the introduction of mumps-containing vaccine in Lao PDR: results from a nationwide cross-sectional population-based survey
Objective: Mumps-containing vaccine is currently not a component of the national immunization schedule in Lao People's Democratic Republic (PDR). Mumps itself is not a notifiable disease in the country and the seroprevalence of anti-mumps immunoglobulin G (IgG) in the general population is unknown. In this study, anti-mumps IgG was measured in 2058 blood samples to evaluate population immunity in the country. Results: The seroprevalence of anti-mumps IgG showed a gradual increase with increasing age, starting at 10.6% (95% CI 7.4-13.7) in participants aged 1-2 years, and almost plateaued at about 75% in individuals older than 11-12 years, though it still tended toward a small increase up to 89.6% (95% CI 86.6-92.6) in participants aged 40 years or older. Compared with the results of previous studies, this increase with increasing age is less marked and the plateau of anti-mumps seroprevalence is lower. We attribute this result mainly to the lower population density in Lao PDR.